Pharmorubicin RD TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: epirubicin
Pack: Pharmorubicin RD 50 mg powder for injection, 1 vial
Brand name
(ARTG)
: PHARMORUBICIN RD (RAPID DISSOLUTION) epirubicin hydrochloride 50mg powder for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
PHARMORUBICIN has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: breast cancer; gastric cancer; ovarian cancer; small cell lung cancer; lymphoma (non-Hodgkin's lymphoma); advanced/metastatic soft tissue sarcoma; superficial bladder cancer (Tis; Ta). In bladder cancer, PHARMORUBICIN is also indicated in the prophylaxis of recurrence after transurethral resection of stage T1 papillary cancers and stage Ta multifocal papillary cancers (Grade 2 and 3).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous
- Red/orange freeze-dried crystalline powder
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial x 50mg pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient epirubicin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems